Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Am Heart J
    January 2018
  1. MAURI L, Kario K, Basile J, Daemen J, et al
    A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Am Heart J. 2018;195:115-129.
    >> Share

    October 2017
  2. WAKSMAN R, Bakris GL, Steinvil A, Garcia-Garcia H, et al
    High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3.
    Am Heart J. 2017;192:76-84.
    >> Share

    July 2017
  3. AUSTIN C, Burger C, Kane G, Safford R, et al
    High-risk echocardiographic features predict mortality in pulmonary arterial hypertension.
    Am Heart J. 2017;189:167-176.
    >> Share

    June 2017
  4. NEAL B, Tian M, Li N, Elliott P, et al
    Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)-A large-scale cluster randomized controlled trial.
    Am Heart J. 2017;188:109-117.
    >> Share

    April 2017
  5. VEMULAPALLI S, Deng L, Patel MR, Kilgore ML, et al
    National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
    Am Heart J. 2017;186:29-39.
    >> Share

  6. MORAWSKI K, Ghazinouri R, Krumme A, McDonough J, et al
    Rationale and design of the Medication adherence Improvement Support App For Engagement-Blood Pressure (MedISAFE-BP) trial.
    Am Heart J. 2017;186:40-47.
    >> Share

    March 2017
  7. WILLIAMS RB, Bishop GD, Haberstick BC, Smolen A, et al
    Population differences in associations of serotonin transporter promoter polymorphism (5HTTLPR) di- and triallelic genotypes with blood pressure and hypertension prevalence.
    Am Heart J. 2017;185:110-122.
    >> Share

  8. NAKANISHI K, Jin Z, Homma S, Elkind MS, et al
    Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study.
    Am Heart J. 2017;185:85-92.
    >> Share

  9. CHAMBERLAIN AM, Alonso A, Gersh BJ, Manemann SM, et al
    Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Am Heart J. 2017;185:74-84.
    >> Share

  10. KUPSKY DF, Ahmed AM, Sakr S, Qureshi WT, et al
    Cardiorespiratory fitness and incident heart failure: The Henry Ford ExercIse Testing (FIT) Project.
    Am Heart J. 2017;185:35-42.
    >> Share

  11. KHETAN A, Purushothaman R, Zullo M, Gupta R, et al
    Rationale and design of a cluster-randomized controlled trial to evaluate the effects of a community health worker-based program for cardiovascular risk factor control in India.
    Am Heart J. 2017;185:161-172.
    >> Share

    November 2016
  12. RINNSTROM D, Dellborg M, Thilen U, Sorensson P, et al
    Hypertension in adults with repaired coarctation of the aorta.
    Am Heart J. 2016;181:10-15.
    >> Share

    October 2016
  13. SANGHVI K, McGrew A, Hegde K
    Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
    Am Heart J. 2016;180:e1-2.
    >> Share

  14. MARTIN-CABEZAS R, Seelam N, Petit C, Agossa K, et al
    Association between periodontitis and arterial hypertension: A systematic review and meta-analysis.
    Am Heart J. 2016;180:98-112.
    >> Share

  15. MACIVER DH, Adeniran I, MacIver IR, Revell A, et al
    Physiological mechanisms of pulmonary hypertension.
    Am Heart J. 2016;180:1-11.
    >> Share

    September 2016
  16. BUCK J, Kaboli P, Gage BF, Cram P, et al
    Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.
    Am Heart J. 2016;179:186-91.
    >> Share

  17. BHATNAGAR A, Bolli R, Johnstone BH, Traverse JH, et al
    Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
    Am Heart J. 2016;179:142-50.
    >> Share

  18. THUNE JJ, Pehrson S, Nielsen JC, Haarbo J, et al
    Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Am Heart J. 2016;179:136-41.
    >> Share

    August 2016
  19. MALEBRANCHE R, Tabou Moyo C, Morisset PH, Raphael NA, et al
    Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
    Am Heart J. 2016;178:151-60.
    >> Share

  20. VEMULAPALLI S, Hellkamp AS, Jones WS, Piccini JP, et al
    Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial.
    Am Heart J. 2016;178:74-84.
    >> Share

  21. FROHLICH H, Nelges C, Tager T, Schwenger V, et al
    Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Am Heart J. 2016;178:28-36.
    >> Share

  22. AKERBLOM A, Clare RM, Lokhnygina Y, Wallentin L, et al
    Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.
    Am Heart J. 2016;178:1-8.
    >> Share

    July 2016
  23. PEGUERO JG, Lo Presti S, Issa O, Podesta C, et al
    Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2.
    Am Heart J. 2016;177:153-9.
    >> Share

    January 2016
  24. KANDZARI DE, Kario K, Mahfoud F, Cohen SA, et al
    The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
    Am Heart J. 2016;171:82-91.
    >> Share

    October 2015
  25. WEIJMANS M, van der Graaf Y, de Borst GJ, Asselbergs FW, et al
    The relation between the presence of cardiovascular disease and vascular risk factors in offspring and the occurrence of new vascular events in their parents already at high vascular risk.
    Am Heart J. 2015;170:744-752.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016